"183293-82-5"@en . . "Gemcabene"@en . . . . . . . . . . . . . . . . . . . . . . . . . . "Investigated for use/treatment in atherosclerosis, cardiovascular disorders, and hyperlipidemia."@en . "Gemcabene is a new drug that lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C)."@en . . . . . . "investigational"@en . . "# Mandema JW, Hermann D, Wang W, Sheiner T, Milad M, Bakker-Arkema R, Hartman D: Model-based development of gemcabene, a new lipid-altering agent. AAPS J. 2005 Oct 7;7(3):E513-22. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16353929 # Bays HE, McKenney JM, Dujovne CA, Schrott HG, Zema MJ, Nyberg J, MacDougall DE: Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol. Am J Cardiol. 2003 Sep 1;92(5):538-43. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12943873"@en .